---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-24-000772"
form_type: "8-K"
ticker: null
cik: "0001602078"
company_name: "Nemaura Medical Inc."
filed_at: "2024-05-17T23:59:59+00:00"
generated_at: "2026-06-01T15:48:28.465675+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve reverse stock split authorization at ratio of 1:10 to 1:150

## Summary
- Approved by written consent on May 9, 2024; board to determine final ratio.
- Fractional shares resulting from reverse split will be rounded up to nearest whole share.
- No other matters were submitted to a vote of security holders.

## SEC filing metadata
- accession: 0001079973-24-000772
- form_type: 8-K
- cik: 0001602078
- company_name: Nemaura Medical Inc.
- filed_at: 2024-05-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1602078/000107997324000772/0001079973-24-000772-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1602078/000107997324000772/nmra_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-24-000772
- JSON: https://secwatch.observer/filing/0001079973-24-000772.json
- Plain text: https://secwatch.observer/filing/0001079973-24-000772.txt

## Source-grounded claims
- claim_id: b05046be90bc53e32bd2432fb58aacdc217478e4
  claim: Nemaura Medical Inc. shareholders approved Authorization of amendments to the Articles of Incorporation to effect a reverse stock split of the common stock ranging in ratio between 1-for-10 and 1-for-150 at the 2024-05-09 meeting.
  evidence_excerpt: On May 9, 2024, the Shareholders of Nemaura Medical Inc. (the “Company”) approved by written consent to authorize amendments to the Articles of Incorporation of the Company (the “Articles”) to effect a reverse stock split of the common stock, par value $0.001 per share, of the Company (the “Common Stock”) ranging in ratio between 1-for-10 and 1-for-150, with one share of Common Stock being issued for a range of between each 10 and 150 shares of Common Stock issued and outstanding, with such final ratio to be determined by the Board following approval thereof by the shareholders of the Company, with any fractional shares of Common Stock resulting therefrom being rounded up to the nearest whole share of Common Stock (the “Reverse Split”), and to amend the Articles to effect the Reverse Split.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1602078/000107997324000772/0001079973-24-000772-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.